Ocugen to Present at 2018 BIO CEO & Investor Conference

February 6, 2018

Responsive image

MALVERN, Pa., Feb. 6, 2018 /PRNewswire/ — Ocugen, Inc., a rapidly growing ophthalmology company developing a rich clinical pipeline of innovative therapies that address rare and underserved ocular diseases, today announced that it will present at the 2018 BIO CEO & Investor…

Category: Precious Metals